Pulmonary renal syndromes: A pulmonologist's view

Clinical Queries: Nephrology - Tập 4 - Trang 1-8 - 2015
Alok Nath1, Srinivas Rajagopala2
1Associate Professor, Department of Pulmonary Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh 226014, India
2Assistant Professor, Department of Medicine & Medical Intensive Care Unit, Jawaharlal Nehru Institute of Postgraduate Medical Education & Research, Dhanvantri Nagar, Puducherry 605006, India

Tài liệu tham khảo

Goodpasture, 1919, The significance of certain pulmonary lesions in relation to the etiology of influenza, Am J Med Sci, 158, 863, 10.1097/00000441-191911000-00012 Gibelin, 2011, Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement, Semin Respir Crit care Med, 32, 264, 10.1055/s-0031-1279824 Brisson, 2001, Epidemiology of varicella zoster virus infection in Canada and the United Kingdom, Epidemiol Infect, 127, 305, 10.1017/S0950268801005921 Knight, 2006, Increasing incidence of Wegener's granulomatosis in Sweden, 1975–2001, J Rheumatol, 33, 2060 Koldingsnes, 2000, Epidemiology of Wegener's granulomatosis in northern Norway, Arthritis Rheum, 43, 2481, 10.1002/1529-0131(200011)43:11<2481::AID-ANR15>3.0.CO;2-6 Watts, 2009, Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database, Arthritis Rheum, 61, 1412, 10.1002/art.24544 Ntatsaki, 2010, Epidemiology of ANCA-associated vasculitis, Rheum Dis Clin North Am, 36, 447, 10.1016/j.rdc.2010.04.002 Lane, 2003, Are environmental factors important in primary systemic vasculitis? A case-control study, Arthritis Rheum, 48, 814, 10.1002/art.10830 Csernok, 2010, Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis, Curr Opin Rheumatol, 22, 43, 10.1097/BOR.0b013e3283323538 Nakazawa, 2012, Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis, Arthritis Rheum, 64, 3779, 10.1002/art.34619 Wechsler, 2009, Churg-strauss syndrome in patients treated with omalizumab, Chest, 136, 507, 10.1378/chest.08-2990 Bibby, 2010, Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database, Thorax, 65, 132, 10.1136/thx.2009.120972 Pai, 1998, Hydrocarbon exposure and glomerulonephritis due to systemic vasculitis, Nephrol Dial Transplant: official publication of the European Dialysis and Transplant Association – European Renal Association, 13, 1321, 10.1093/ndt/13.5.1321 Davies, 2005, Small vessel vasculitis, Cardiovasc Pathol: the official journal of the Society for Cardiovascular Pathology, 14, 335, 10.1016/j.carpath.2005.08.001 Lau, 2005, Glomerulonephritis, Adolesc Med Clin, 16, 67, 10.1016/j.admecli.2004.09.008 Kalluri, 1996, The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen, J Biol Chem, 271, 9062, 10.1074/jbc.271.15.9062 Ryan, 1998, Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition, Clin Exp Immunol, 113, 17, 10.1046/j.1365-2249.1998.00623.x Hellmark, 1999, Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease, Kidney Int, 55, 936, 10.1046/j.1523-1755.1999.055003936.x Sirvent, 2007, Goodpasture's syndrome in a patient using cocaine – a case report and review of the literature, Clin Nephrol, 68, 182, 10.5414/CNP68182 Munoz, 2010, The role of defective clearance of apoptotic cells in systemic autoimmunity, Nat Rev Rheumatol, 6, 280, 10.1038/nrrheum.2010.46 Shao, 2011, Disturbances of apoptotic cell clearance in systemic lupus erythematosus, Arthritis Res Ther, 13, 202, 10.1186/ar3206 Sheriff, 2004, Apoptosis and systemic lupus erythematosus, Rheumatic Dis Clin of North Am, 30, 505, 10.1016/j.rdc.2004.04.006 Shin, 2011, Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells, Curr Opin Rheumatol, 23, 444, 10.1097/BOR.0b013e328349a255 Konya, 2014, The role of T cells in systemic lupus erythematosus: an update, Curr Opin Rheumatol, 26, 493, 10.1097/BOR.0000000000000082 Jennette, 2013, Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis, Annu Rev Pathol, 8, 139, 10.1146/annurev-pathol-011811-132453 Bansal, 2004, Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement, Ann Allergy Asthma Immunol: official publication of the American College of Allergy, Asthma, & Immunology, 93, 398, 10.1016/S1081-1206(10)61400-7 Schneeweis, 2010, Increased levels of BLyS and sVCAM-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV), Clin Exp Rheumatol, 28, 62 Wathen, 1987, Circulating anti-neutrophil antibodies in systemic vasculitis, Lancet, 1, 1037, 10.1016/S0140-6736(87)92310-5 Kain, 2008, Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis, Nat Med, 14, 1088, 10.1038/nm.1874 Davies, 1997, Molecular mimicry: can epitope mimicry induce autoimmune disease?, Immunol Cell Biol, 75, 113, 10.1038/icb.1997.16 West, 2013, Pulmonary-renal syndrome: a life threatening but treatable condition, Postgrad Med J, 89, 274, 10.1136/postgradmedj-2012-131416 Al bshabshe, 2010, Pulmonary renal syndrome associated with Wegener's granulomatosis: a case report and review of literature, Clin Exp Nephrol, 14, 80, 10.1007/s10157-009-0223-1 Merino, 2011, A retrospective study on outcome of microscopic polyangiitis in chronic renal replacement therapy, Nephrol Dial Transplant: official publication of the European Dialysis and Transplant Association – European Renal Association, 26, 1360, 10.1093/ndt/gfq523 Grau, 2008, Churg-Strauss syndrome: 2005–2008 update, Curr Rheumatol Rep, 10, 453, 10.1007/s11926-008-0074-x Della Rossa, 2002, Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre, Rheumatology (Oxford), 41, 1286, 10.1093/rheumatology/41.11.1286 Sewell, 1996, Systemic lupus erythematosus as a cause of the pulmonary renal syndrome, J Intern Med, 240, 43 Specks, 2001, Diffuse alveolar hemorrhage syndromes, Curr Opin Rheumatol, 13, 12, 10.1097/00002281-200101000-00003 Collard, 2004, Diffuse alveolar hemorrhage, Clin Chest Med, 25, 583, 10.1016/j.ccm.2004.04.007 Jayne, 2007, Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis, J Am Soc Nephrol, 18, 2180, 10.1681/ASN.2007010090 Faurschou, 2012, Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis, Arthritis Rheum, 64, 3472, 10.1002/art.34547 Specks, 2013, Efficacy of remission-induction regimens for ANCA-associated vasculitis, N Engl J Med, 369, 417, 10.1056/NEJMoa1213277 Jones, 2010, Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis, N Engl J Med, 363, 211, 10.1056/NEJMoa0909169 2005, Etanercept plus standard therapy for Wegener's granulomatosis, N Engl J Med, 352, 351, 10.1056/NEJMoa041884 Jayne, 2003, A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies, N Engl J Med, 349, 36, 10.1056/NEJMoa020286 Pagnoux, 2008, Azathioprine or methotrexate maintenance for ANCA-associated vasculitis, N Engl J Med, 359, 2790, 10.1056/NEJMoa0802311 Hiemstra, 2010, Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial, JAMA, 304, 2381, 10.1001/jama.2010.1658 Luqmani, 1994, Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis, QJM, 87, 671 Exley, 1997, Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides, Arthritis Rheum, 40, 371, 10.1002/art.1780400222 Matteson, 1996, Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort, Am J Med, 101, 129, 10.1016/S0002-9343(96)80066-0 Tomasson, 2012, Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis – a meta-analysis, Rheumatology (Oxford), 51, 100, 10.1093/rheumatology/ker280 Girard, 2001, Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study, Rheumatology (Oxford), 40, 147, 10.1093/rheumatology/40.2.147 Rodriguez, 2002, Pulmonary-renal syndromes in the intensive care unit, Crit Care Clin, 18, 881, 10.1016/S0749-0704(02)00029-5 Martinez-Martinez, 2014, Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhage, J Rheumatol, 10.3899/jrheum.130927